✦ LIBER ✦

Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen

✍ Scribed by Winder, T; Giamas, G; Wilson, P M; Zhang, W; Yang, D; Bohanes, P; Ning, Y; Gerger, A; Stebbing, J; Lenz, H-J

Book ID: 120047091
Publisher: Nature Publishing Group
Year: 2013
Tongue: English
Weight: 403 KB
Volume: 14
Category: Article
ISSN: 1470-269X
DOI: 10.1038/tpj.2013.8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estrogen Receptor Alpha Phosphorylated a

Estrogen Receptor Alpha Phosphorylated at Tyrosine 537 is Associated with Poor Clinical Outcome in Breast Cancer Patients Treated with Tamoxifen

✍ Georgios P. Skliris; Zoann Nugent; Peter H. Watson; Leigh C. Murphy 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 298 KB

Epidermal growth factor receptor (EGFR)

Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer

✍ Looket Dihge; Pär-Ola Bendahl; Dorthe Grabau; Jorma Isola; Kristina Lövgren; Lis 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 212 KB

Invasiveness gene signature predicts a f

Invasiveness gene signature predicts a favorable outcome also in estrogen receptor-positive primary breast cancers treated with adjuvant tamoxifen

✍ Danila Coradini; Manuela Gariboldi; Maya Fedeli; Marco A. Pierotti; Maria Grazia 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 133 KB

Expression of insulin-like growth factor

Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status

✍ Jose A. Figueroa; James G. Jackson; William L. McGuire; Robert F. Krywicki; Doug 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 875 KB

The insulin-like growth factors (IGFs) have been implicated in the growth regulation of human breast cancer. Since the lCFs are associated with specific binding proteins (ICFBPs) which may modulate receptor/ligand interactions, production of IGFBPs by breast cancer cells could alter their IGF-depend

Insulin-like growth factor receptor 1 pa

Insulin-like growth factor receptor 1 pathway signature correlates with adverse clinical outcome in ovarian cancer

✍ B. Winterhoff; P. Haluska; K. Kalli; W. Cliby; B. Gostout; A. Oberg; M. Maurer; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Epidermal growth factor receptor polymor

Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib

✍ Liu, G; Gurubhagavatula, S; Zhou, W; Wang, Z; Yeap, B Y; Asomaning, K; Su, L; He 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB